Intuitive Surgical (NASDAQ:ISRG) PT Raised to $549.00 at Wells Fargo & Company

Intuitive Surgical (NASDAQ:ISRG) had its price target hoisted by stock analysts at Wells Fargo & Company from $466.00 to $549.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s price target suggests a potential upside of 5.34% from the stock’s current price.

Other equities research analysts have also recently issued reports about the company. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Barclays lifted their price target on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. Evercore ISI upped their price objective on Intuitive Surgical from $410.00 to $475.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Raymond James raised their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Finally, BTIG Research boosted their target price on Intuitive Surgical from $494.00 to $518.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $521.15 on Friday. The stock’s 50-day simple moving average is $483.85 and its 200 day simple moving average is $438.17. The company has a market cap of $184.85 billion, a P/E ratio of 94.07, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical has a 52-week low of $254.85 and a 52-week high of $523.34.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company’s quarterly revenue was up 14.5% on a year-over-year basis. During the same period in the previous year, the company earned $1.18 earnings per share. As a group, equities analysts predict that Intuitive Surgical will post 5.22 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Monday, July 29th. The shares were sold at an average price of $446.60, for a total value of $167,921.60. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,458,979.60. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, insider Mark Brosius sold 2,115 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the sale, the insider now directly owns 295 shares in the company, valued at approximately $145,113.45. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $446.60, for a total value of $167,921.60. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,458,979.60. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 53,120 shares of company stock worth $25,528,753. Insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently bought and sold shares of ISRG. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.6% in the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after purchasing an additional 493,126 shares during the period. Capital World Investors raised its holdings in shares of Intuitive Surgical by 1.0% in the 1st quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock valued at $2,907,079,000 after acquiring an additional 73,634 shares in the last quarter. Jennison Associates LLC increased its holdings in shares of Intuitive Surgical by 4.6% in the 1st quarter. Jennison Associates LLC now owns 4,488,343 shares of the medical equipment provider’s stock worth $1,791,253,000 after buying an additional 198,483 shares during the last quarter. American Century Companies Inc. raised its position in Intuitive Surgical by 3.0% during the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after purchasing an additional 70,556 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its position in Intuitive Surgical by 1.6% in the 2nd quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock worth $881,380,000 after buying an additional 30,449 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.